EYPT:NASDAQ
EyePoint Inc
$0.40
arrow_downward
-1.23%(-0.0049) 1D
$0.40
arrow_upward
+2.03% (+0.0080)bedtimeAfter hours
Closed: Nov 4, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
$0.39
High
$0.41
Low
$0.38
Mkt. cap
34.05M
Avg. vol.
13.02M
Volume
3.07M
52-wk high
$19.01
52-wk low
$0.34
EPS
-$3.74
Beta
1.84
Shares outstanding
86.21M
No. of employees
214
Open
$0.39
High
$0.41
Low
$0.38
Mkt. cap
34.05M
Avg. vol.
13.02M
Volume
3.07M
52-wk high
$19.01
52-wk low
$0.34
EPS
-$3.74
Beta
1.84
Shares outstanding
86.21M
No. of employees
214
News stories
From web sources and news partners
KITV
·
1 hour ago
Dow has best post-midterm elections day in 44 years as Democrats take control of Congress
ChartMill
·
4 hours ago
S&P 500 After-Hours Losers: FICO, EXPE, QCOM Lead Postmarket Declines
Traders Union
·
3 hours ago
Michael Kantro: Correlation between cap and equal-weighted S&P 500 falls to 37%
BeInCrypto
·
38 minutes ago
SK Hynix Sheds Nearly 8% While Dow Jumps: What Is Seoul Pricing In?
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Industry-
Websiteeyepoint.bio